CORC

浏览/检索结果: 共3条,第1-3条 帮助

限定条件                        
已选(0)清除 条数/页:   排序方式:
First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 会议论文
作者:  Zhang, H.;  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y.
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
Mutation status and targeted therapeutic efficacy of advanced non-small cell lung cancer: A real-world study of NSCLC in China (preCAPTRA-LUNG) 会议论文
作者:  Liang, H.;  Song, X.;  Zhang, Y.;  Zhang, S.;  Li, F.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文
作者:  Zhang, Q.;  Xu, B.;  Zhang, Q.;  Sun, T.;  Li, W.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace